TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
33.37
-1.62 (-4.63%)
May 13, 2025, 4:00 PM - Market closed
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
$1,143,154
Profits / Employee
$115,828
Market Cap
4.87B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TGTX News
- 8 days ago - TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga
- 8 days ago - TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges - Seeking Alpha
- 8 days ago - TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewsWire
- 13 days ago - TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 4 weeks ago - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 5 weeks ago - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - GlobeNewsWire
- 7 weeks ago - Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher - Benzinga